Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Casesneurology-neurodisability-and-neuromuscular

Paeds Cases · neurology-neurodisability-and-neuromuscular

Counsel the parents of a child with a first demyelinating event — OSCE

OSCE communication and shared decision-making station: explaining to frightened parents that their six-year-old's drowsiness, irritability, and hemiparesis four days after a viral illness is acute disseminated encephalomyelitis - a first demyelinating event - conveying the immediate treatment with high-dose corticosteroids, the antibody-led workup that will determine the long-term diagnosis, and the principle that the long-term treatment depends on the antibody result, while managing uncertainty and keeping urgency without alarming the family.

osce communication and shared decision-making3 min readVerification in progress

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
On this page
Study tools

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
Prompt
The parents of a previously well six-year-old boy are seen on the ward. Four days after a viral cold, their son became drowsy and irritable, then over a day developed a weak right side and slurred speech, and his conscious level has fluctuated. The brain scan shows widespread inflammation in the brain, and the team has started high-dose steroids and is sending antibody tests. The parents are frightened, do not understand why their child's brain is inflamed after a simple cold, have read about multiple sclerosis on the internet, and want to know whether he will recover and whether he needs long-term treatment. Counsel them.

Candidate brief and communication tasks

The candidate enters the room to find the parents anxious and holding a phone showing a multiple-sclerosis webpage. The task is to counsel them over eight minutes: explain what has happened to their son in plain language, justify the immediate treatment, outline the antibody-led workup, set realistic expectations about recovery and the long-term outlook, and address the multiple-sclerosis worry without false reassurance. The communication skill is to convey urgency without alarm and to share the decision-making honestly while the diagnosis is still resolving. [1]

The first task is to name the event in plain language. The candidate explains that their son's immune system, instead of clearing the recent cold, has mistakenly attacked the protective coating of the nerves in his brain - a first demyelinating event called acute disseminated encephalomyelitis, or ADEM. The candidate links the bedside picture - drowsiness, irritability, the weak side, the slurred speech - to the widespread inflammation on the scan, and explains that this is why he is drowsy: the inflammation is disrupting how the nerves conduct, and the treatment is to calm that inflammation quickly. [1]

The second task is to justify the immediate treatment and set the recovery expectation. The candidate explains that the team has started high-dose steroid medicine through a drip - the standard first treatment for this kind of inflammation - and that most children with ADEM recover well over the coming weeks, though recovery is gradual and rehabilitation will help. The candidate is honest that the team will watch the response over the first two to three days and, if the inflammation is not settling, will add other immune treatments such as immunoglobulin or a blood-cleaning procedure called plasma exchange. [2]

The third task is to address the multiple-sclerosis worry and the antibody workup. The candidate acknowledges what the parents have read, and explains that ADEM is a different disorder from multiple sclerosis in most children, but that the team is sending specific blood tests - antibody tests - to be certain, because there are four related disorders in this family and the long-term treatment depends on getting that answer right. The candidate explains that the team will not start any long-term medicine until those antibody results are back - in particular, that a multiple-sclerosis medicine would not be used unless the tests confirm multiple sclerosis - and that the answer will be available within a few weeks. [1] [3]

The fourth task is to share the decision-making and close the loop. The candidate invites the parents' questions, checks their understanding, agrees on a plan for the next forty-eight hours (the steroid response, the escalation plan, the rehabilitation referral), and arranges a follow-up conversation once the antibody results return. The candidate closes by affirming that the immediate priority is calming the inflammation and supporting recovery, that the team will share the antibody results and their meaning as soon as they are available, and that a named doctor and nurse will be the family's point of contact throughout. [2] [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler, 2013.PMID 23572237
  2. [2]Bruijstens AL, Wendel EM, Lechner C, Bartels F, Finke C, Breu M, et al. E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol, 2020.PMID 33176999
  3. [3]Margoni M, Preziosa P, Rocca MA, Filippi M. Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD. CNS Drugs, 2026.PMID 42334795
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousCounsel a family on starting levetiracetam for newly diagnosed focal epilepsy — OSCEneurology-neurodisability-and-neuromuscularNextDuchenne and Becker muscular dystrophy: Caseneurology-neurodisability-and-neuromuscular